oa “Kan reactievermogen beïnvloeden – Ik kan dan uitslag krijgen of zoiets?”

References

1. Aspden, P., Wolcott, J. A., Bootman, J. L., & Cronenwett, L. R. (2006). Preventing medication errors (pp. 409-46). Washington, DC: National Academies Press.
   [Google Scholar]
2. Bailey, S. C., Navaratnam, P., Black, H., Russell, A. L., & Wolf, M. S. (2015). Advancing best practices for prescription drug labeling. Annals of Pharmacotherapy, 49(11), 1222-1236.
   [Google Scholar]
3. Bailey, S. C., Sarkar, U., Chen, A. H., Schillinger, D., & Wolf, M. S. (2012). Evaluation of language concordant, patient-centered drug label instructions. Journal of General Internal Medicine, 27(12), 1707-1713.
   [Google Scholar]
4. Bailey, S. C., Wolf, M. S., Lopez, A., Russell, A., Chen, A. H., Schillinger, D., … & Sarkar, U. (2014). Expanding the Universal Medication Schedule: a patient-centred approach. BMJ open, 4(1), e003699.
   [Google Scholar]
5. Berkman, N. D., Sheridan, S. L., Donahue, K. E., Halpern, D. J., & Crotty, K. (2011). Low health literacy and health outcomes: an updated systematic review. Annals of Internal Medicine, 155(2), 97-107.
   [Google Scholar]
6. Borgsteede, S. D., & Heringa, M. (2019). Nature and frequency of dosing instructions on prescription labels in primary care. Pharmacoepidemiology and Drug Safety, 28(8), 1060-1066.
   [Google Scholar]
7. Bostock, S., & Steptoe, A. (2012). Association between low functional health literacy and mortality in older adults: longitudinal cohort study. BMJ, 344:e1602
   [Google Scholar]
8. Botermann, L., Krueger, K., Eickhoff, C., Kloft, C., & Schulz, M. (2016). Patients’ handling of a standardized medication plan: a pilot study and method development. Patient preference and adherence, 10, 621-630.
   [Google Scholar]
9. Davis, T. C., Federman, A. D., Bass, P. F., Jackson, R. H., Middlebrooks, M., Parker, R. M., & Wolf, M. S. (2009). Improving patient understanding of prescription drug label instructions. Journal of General Internal Medicine, 24, 57-62.
   [Google Scholar]
10. DavisT.C., LongS.W., JacksonR.H., MayeauxE.J., GeorgeR.B., MurphyP.W., CrouchM.A. (1993). Rapid estimate of adult literacy in medicine: a shortened screening instrument. Family Medicine, 25(6), 391-395.
    [Google Scholar]
11. Davis, T. C., Wolf, M. S., Bass, P. F., Thompson, J. A., Tilson, H. H., Neuberger, M., & Parker, R. M. (2006). Literacy and misunderstanding prescription drug labels. Annals of Internal Medicine, 145(12), 887-894.
    [Google Scholar]
12. European Commission, Consumer Goods Pharmaceuticals (2009). Guideline on the Readability of the Labeling and Package Leaflet of Medicinal Products for Human Use (Brussels: European Commission, 2009).
    [Google Scholar]
13. Fransen, M. P., Leenaars, K. E., Rowlands, G., Weiss, B. D., Maat, H. P., & Essink-Bot, M. L. (2014). International application of health literacy measures: Adaptation and validation of the newest vital sign in The Netherlands. Patient Education and Counseling, 97(3), 403-409.
    [Google Scholar]
14. Koster, E. S., Blom, L., Winters, N. A., Van Hulten, R. P., & Bouvy, M. L. (2014). Interpretation of drug label instructions: A study among four immigrants groups in the Netherlands. International Journal of Clinical Pharmacy, 36(2), 274-281. https://doi.org/10.1007/s11096-013-9873-x
    [Google Scholar]
15. Koster, E. S., Philbert, D., & Bouvy, M. L. (2015). Health literacy among pharmacy visitors in the Netherlands. Pharmacoepidemiology and Drug Safety, 24(7), 716-721. https://doi.org/10.1002/pds.3803
    [Google Scholar]
16. Lentz, L. R., & Pander Maat, H. (2010). Een leesbare bijsluiter. Tijdschrift voor Taalbeheersing, 32(2), 128-151.
    [Google Scholar]
17. Locke, M. R., Shiyanbola, O. O., & Gripentrog, E. (2014). Improving prescription auxiliary labels to increase patient understanding. Journal of the American Pharmacists Association, 54(3), 267-274.
    [Google Scholar]
18. Maghroudi, E., van Hooijdonk, C. M. J., van Dijk, L., Boland, G., de Haas, C., Journée-Gilissen, M., van der Velden, J., Vervloet, M., Westerhof, H., Rademakers, J. J. D. J. M., & Borgsteede, S. D. (2020). Development of Comprehensible Prescription Label Instructions: A Study Protocol for a Mixed-Methods Approach. Frontiers in Pharmacology, 11, [981].
    [Google Scholar]
19. Maghroudi, E., Van Hooijdonk, C. M. J., Van de Bruinhorst, H., Van Dijk, L., Rademakers, J., & Borgsteede, S. D. (2021). The impact of textual elements on the comprehensibility of drug label instructions (DLIs): A systematic review. PloS one, 16(5), e0250238.
    [Google Scholar]
20. Martins, S. F., van Mil, J. F., & Da Costa, F. A. (2015). The organizational framework of community pharmacies in Europe. International journal of clinical pharmacy, 37, 896-905.
    [Google Scholar]
21. McCarthy, D. M., Davis, T. C., King, J. P., Mullen, R. J., Bailey, S. C., Serper, M., … & Wolf, M. S. (2013). Take-Wait-Stop: a patient-centered strategy for writing PRN medication instructions. Journal of Health Communication, 18(sup1), 40-48.
    [Google Scholar]
22. NijmanJ., HendriksM., BrabersA., JongJ. de, & RademakersJ. (2014). Patient activation and health literacy as predictors of health information use in a general sample of Dutch health care consumers. Journal of Health Communication: International Perspectives, 19(8), 955-969.
    [Google Scholar]
23. Nutbeam, D. (2000). Health literacy as a public health goal; a challenge for contemporary health education and communication strategies into 21st century. Health Oromotion International, 15(3), 259-267.
    [Google Scholar]
24. NutbeamD. (2009). Defining and measuring health literacy: what can we learn from literacy studies?Int. J. Public Health, 54(5), 303–305.
    [Google Scholar]
25. Pires, C., Vigário, M., & Cavaco, A. (2016). Factors influencing subjects’ comprehension of a set of medicine package inserts. International Journal of Clinical Pharmacy, 38, 888-898.
    [Google Scholar]
26. Rademakers, J. (2014). Kennissynthese: gezondheidsvaardigheden: niet voor iedereen vanzelfsprekend. NIVEL
    [Google Scholar]
27. Samaranayake, N. R., Bandara, W. G., & Manchanayake, C. M. (2018). A narrative review on do’s and don’ts in prescription label writing–lessons for pharmacists. Integrated Pharmacy Research and Practice, 53-66.
    [Google Scholar]
28. Sahm, L. J., Wolf, M. S., Curtis, L. M., Behan, R., Brennan, M., Gallwey, H., & Mc Carthy, S. (2012). What’s in a label? An exploratory study of patient-centered drug instructions. European Journal of Clinical Pharmacology, 68(5), 777-782
    [Google Scholar]
29. SørensonK, Van den BrouckeS, FullamJ, DoyleG, PelikanJ., et al. (2012). Health literacy and public health: a systematic review and integration of definitions and models. BMC Public Health, 25, 12:80.
    [Google Scholar]
30. Sturkenboom, M. C. J. M., Van Den Bemt, P. M. L. A., De Smet, P. A. G. M., & Hek, K. (2017). Eindrapport: Vervolgonderzoek Medicatieveiligheid. Erasmus MC, NIVEL, Radboud UMC en PHARMO
    [Google Scholar]
31. Talevski, J., Wong Shee, A., Rasmussen, B., Kemp, G., & Beauchamp, A. (2020). Teach-back: A systematic review of implementation and impacts. PloS one, 15(4), e0231350.
    [Google Scholar]
32. Van Mil, J. F. (2005). Pharmaceutical care in community pharmacy: practice and research in the Netherlands. Annals of Pharmacotherapy, 39(10), 1720-1725.
    [Google Scholar]
33. Webb, J., Davis, T. C., Bernadella, P., Clayman, M. L., Parker, R. M., Adler, D., & Wolf, M. S. (2008). Patient-centered approach for improving prescription drug warning labels. Patient Education and Counseling, 72(3), 443-449.
    [Google Scholar]
34. Weiss, B. D., Mays, M. Z., Martz, W., Castro, K. M., DeWalt, D. A., Pignone, M. P., et al. (2005). Quick assessment of literacy in primary care: the newest vital sign. The Annals of Family Medicine, 3(6), 514-522.
    [Google Scholar]
35. Willems, A. E. M., Heijmans, M., Brabers, A. E. M., & Rademakers, J. (2022). Gezondheidsvaardigheden in Nederland: factsheet cijfers 2021.
    [Google Scholar]
36. Wolf, M. S., Davis, T. C., Curtis, L. M., Bailey, S. C., Knox, J. P., Bergeron, A., … & Wood, A. J. (2016). A patient-centered prescription drug label to promote appropriate medication use and adherence. Journal of General Internal Medicine, 31, 1482-148.
    [Google Scholar]
37. Wolf, M. S., Davis, T. C., Curtis, L. M., Webb, J. A., Bailey, S. C., Shrank, W. H., … & Wood, A. J. (2011). Effect of standardized, patient-centered label instructions to improve comprehension of prescription drug use. Medical care, 49(1), 96-100.
    [Google Scholar]
38. Wolf, M. S., Davis, T. C., Shrank, W., Rapp, D. N., Bass, P. F., Connor, U. M., … & Parker, R. M. (2007). To err is human: patient misinterpretations of prescription drug label instructions. Patient Education and Counseling, 67(3), 293-300.
    [Google Scholar]
39. Wolf, M. S., Davis, T. C., Tilson, H. H., Bass III, P. F., & Parker, R. M. (2006). Misunderstanding of prescription drug warning labels among patients with low literacy. American Journal of Health-System Pharmacy, 63(11), 1048-1055.
    [Google Scholar]
40. Yuan, H. C. T., Raynor, D. K., & Aslani, P. (2019). Comparison of international regulations for written medicine information (WMI) on prescription medicines. Therapeutic Innovation & Regulatory Science, 53, 215-226.
    [Google Scholar]